Cheng-Yuan Peng

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 42

Top Venues

Alimentary pharmacology & therapeutics

Liver international : official journal of the International Association for the Study of the Liver

Journal of gastroenterology and hepatology

Cancers

China Medical University Hospital

Harvard University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

China Medical University Hospital Feb 10 2003

Taiwan

Director :: Division of Hepatogastroenterology, Department of Internal Medicine

China Medical University Hospital Jul 01 2002 - Feb 10 2003

Taiwan

Attending Physician :: Division of Hepatogastroenterology, Department of Internal Medicine

Linkou Chang Gung Memorial Hospital Dec 01 1999 - Jun 30 2002

Taiwan

Attending Physician :: Division of Hepatogastroenterology, Department of Internal Medicine

Linkou Chang Gung Memorial Hospital Sep 01 1997 - Nov 30 1999

Taiwan

Fellowship :: Division of Hepatogastroenterology, Department of Internal Medicine

National Taiwan University Hospital Jul 01 1989 - Jun 30 1992

Taiwan

Residency :: Department of Internal Medicine

Cathay General Hospital Jul 01 1988 - Jun 30 1989

Taiwan

Residency :: Department of Internal Medicine

Education History

Harvard University Sep 01 1992 - Aug 01 1997

United States

PHD :: Committee on Virology, Division of Medical Sciences

Publications

Chien-Hung Chen, Cheng-Yuan Peng
Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir-potential influence of censored observation. Authors' reply. Alimentary pharmacology & therapeutics 59 (1) (2023)
Chien-Hung Chen, Cheng-Yuan Peng
Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir-potential influence of censored observation. Authors' reply. Alimentary pharmacology & therapeutics 59 (1) (2023)
Scott K Fung, Calvin Qian Pan, Grace Lai-Hung Wong, Wai Kay Seto, Sang Hoon Ahn, Chi-Yi Chen, Hie-Won L Hann, Maciej S Jablkowski, Yun Joon Kim, Cihan Yurdaydin, Cheng-Yuan Peng, Tuan Nguyen, Hiroshi Yatsuhashi, John F Flaherty, Leland J Yee, Frida Abramov, Hongyuan Wang, Dzhamal Abdurakhmanov, Young Suk Lim, Maria Buti Ferret
Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks. Alimentary pharmacology & therapeutics (2023)
Chien-Hung Chen, Cheng-Yuan Peng, Tsung-Hui Hu, Jing-Houng Wang, Chao-Hung Hung, Sheng-Nan Lu
Higher rate of HBsAg loss after discontinuation of tenofovir than entecavir in patients with chronic hepatitis B. Alimentary pharmacology & therapeutics (2023)
Chien-Hung Chen, Cheng-Yuan Peng
Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir-potential influence of censored observation. Authors' reply. Alimentary pharmacology & therapeutics 59 (1) (2023)
Yen-Chun Chen, Te-Sheng Chang, Chien-Hung Chen, Pin-Nan Cheng, Ching-Chu Lo, Lein-Ray Mo, Chun-Ting Chen, Chung-Feng Huang, Hsing-Tao Kuo, Yi-Hsiang Huang, Chi-Ming Tai, Cheng-Yuan Peng, Ming-Jong Bair, Ming-Lun Yeh, Chih-Lang Lin, Yung-Chang Lin, Pei-Lun Lee, Lee-Won Chong, Chao-Hung Hung, Jee-Fu Huang, Chi-Chieh Yang, Jui-Ting Hu, Chih-Wen Lin, Chia-Chi Wang, Wei-Wen Su, Tsai-Yuan Hsieh, Chih-Lin Lin, Wei-Lun Tsai, Tzong-Hsi Lee, Guei-Ying Chen, Szu-Jen Wang, Chun-Chao Chang, Sheng-Shun Yang, Wen-Chih Wu, Chia-Sheng Huang, Chou-Kwok Hsiung, Chien-Neng Kao, Pei-Chien Tsai, Chen-Hua Liu, Mei-Hsuan Lee, Chia-Yen Dai, Jia-Horng Kao, Wan-Long Chuang, Han-Chieh Lin, Chi-Yi Chen, Kuo-Chih Tseng, Ming-Lung Yu, null On Behalf Of Tacr Investigators
Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals. Viruses 14 (2) (2022)
Chien-Hung Chen, Tsung-Hui Hu, Jing-Houng Wang, Hsueh-Chou Lai, Chao-Hung Hung, Sheng-Nan Lu, Cheng-Yuan Peng
A Mac-2 Binding Protein Glycosylation Isomer-Based Risk Model Predicts Hepatocellular Carcinoma in HBV-Related Cirrhotic Patients on Antiviral Therapy. Cancers 14 (20) (2022)
Chen-Hua Liu, Hsin-Yun Sun, Cheng-Yuan Peng, Szu-Min Hsieh, Sheng-Shun Yang, Wei-Yu Kao, Yu-Lueng Shih, Chih-Lin Lin, Chun-Jen Liu, Wang-Huei Sheng, Yi-Chun Lo, Wen-Chun Liu, Jo-Hsuan Wu, Tung-Hung Su, Tai-Chung Tseng, Pei-Jer Chen, Chien-Ching Hung, Jia-Horng Kao
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study. Open forum infectious diseases 9 (8) (2022)
Wei-Fan Hsu, Shih-Chao Hsu, Te-Hong Chen, Chien-Hung Lin, Ying-Chun Lin, Yu-Wei Chang, Hung-Wei Wang, Yu-Min Liao, Hsueh-Chou Lai, Cheng-Yuan Peng
Modified Albumin-Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy. Cancers 14 (20) (2022)
Cheng-Yuan Peng
Editorial: tripartite motif 26 inhibits hepatitis B virus replication and its genetic polymorphism predicts response to interferon treatment-towards a better understanding of interferon responsiveness in chronic hepatitis B. Alimentary pharmacology & therapeutics 56 (6) (2022)
Yao-Chun Hsu, Ming-Lun Yeh, Grace Lai-Hung Wong, Chien-Hung Chen, Cheng-Yuan Peng, Maria Buti, Masaru Enomoto, Qing Xie, Huy Trinh, Carmen Preda, Li Liu, Ka-Shing Cheung, Yee Hui Yeo, Joseph Hoang, Chung-Feng Huang, Mar Riveiro-Barciela, Ritsuzo Kozuka, Doina Istratescu, Pei-Chien Tsai, Elena Vargas Accarino, Dong-Hyun Lee, Jia-Ling Wu, Jee Fu Huang, Chia-Yen Dai, Ramsey Cheung, Wan-Long Chuang, Man-Fung Yuen, Vincent Wai-Sun Wong, Ming-Lung Yu, Mindie H Nguyen
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B. The Journal of infectious diseases 224 (11) (2022)
Jason Grebely, Gregory J Dore, Frederick L Altice, Brian Conway, Alain H Litwin, Brianna L Norton, Olav Dalgard, Edward J Gane, Oren Shibolet, Ronald G Nahass, Anne F Luetkemeyer, Cheng-Yuan Peng, David Iser, Isaias Noel Gendrano, Michelle M Kelly, Peggy Hwang, Ernest Asante-Appiah, Barbara A Haber, Eliav Barr, Michael N Robertson, Heather Platt
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study. Annals of internal medicine 175 (9) (2022)
Chih-Lin Lin, Chi-Ming Tai, Jee-Fu Huang, Chun-Jen Liu, Hui-Fen Chen, Pin-Nan Cheng, Chi-Yi Chen, Cheng-Yuan Peng, Chia-Chi Wang, Shih-Han Weng, Tai-Chung Tseng, Jia-Horng Kao
The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan. Journal of gastroenterology and hepatology 37 (10) (2022)
Sheng-Hung Chen, Hsueh-Chou Lai, Wen-Pang Su, Jung-Ta Kao, Po-Heng Chuang, Wei-Fan Hsu, Hung-Wei Wang, Tsung-Lin Hsieh, Hung-Yao Chen, Cheng-Yuan Peng
Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-Term Liver-Related Events in Patients with Chronic Hepatitis C. Canadian journal of gastroenterology & hepatology 2022 (2022)
Wei-Fan Hsu, Hsueh-Chou Lai, Po-Heng Chuang, Wen-Pang Su, Sheng-Hung Chen, Hung-Yao Chen, Hung-Wei Wang, Guan-Tarn Huang, Cheng-Yuan Peng
Posttreatment nonalcoholic fatty liver disease fibrosis scores for predicting liver-related complications in patients with chronic hepatitis C receiving direct-acting antiviral agents. Journal of viral hepatitis 29 (9) (2022)
Chen Chien-Hung, Cheng-Yuan Peng, Yuan-Hung Kuo, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu
Earlier and higher rate of hepatitis B virus relapse after discontinuing tenofovir versus entecavir in HBeAg-positive patients. The Journal of infectious diseases (2021)
Sheng-Hung Chen, Hsueh-Chou Lai, Wen-Pang Su, Jung-Ta Kao, Po-Heng Chuang, Wei-Fan Hsu, Hung-Wei Wang, Tsung-Yu Tsai, Hung-Yao Chen, Cheng-Yuan Peng
Liver and Spleen Stiffness Surveillance Through Elastography During and After Direct-Acting Antiviral Therapy in Patients With Chronic Hepatitis C. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine (2021)
Chi-Yi Chen, Chung-Feng Huang, Pin-Nan Cheng, Kuo-Chih Tseng, Ching-Chu Lo, Hsing-Tao Kuo, Yi-Hsiang Huang, Chi-Ming Tai, Cheng-Yuan Peng, Ming-Jong Bair, Chien-Hung Chen, Ming-Lun Yeh, Chih-Lang Lin, Yung-Chang Lin, Pei-Lun Lee, Lee-Won Chong, Chao-Hung Hung, Jee-Fu Huang, Chi-Chieh Yang, Jui-Ting Hu, Chih-Wen Lin, Chun-Ting Chen, Chia-Chi Wang, Wei-Wen Su, Tsai-Yuan Hsieh, Chih-Lin Lin, Wei-Lun Tsai, Tzong-Hsi Lee, Guei-Ying Chen, Szu-Jen Wang, Chun-Chao Chang, Lein-Ray Mo, Sheng-Shun Yang, Wen-Chih Wu, Chia-Sheng Huang, Chou-Kwok Hsiung, Chien-Neng Kao, Pei-Chien Tsai, Chen-Hua Liu, Mei-Hsuan Lee, Chun-Jen Liu, Chia-Yen Dai, Jia-Horng Kao, Wan-Long Chuang, Han-Chieh Lin, Ming-Lung Yu
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan. Liver international : official journal of the International Association for the Study of the Liver 41 (6) (2021)
Meng-Hsuan Hsieh, Ming-Jong Bair, Pei-Chien Tsai, Kuo-Chih Tseng, Ching-Chu Lo, Chi-Yi Chen, Hsing-Tao Kuo, Chao-Hung Hung, Hsueh-Chou Lai, Cheng-Yuan Peng, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chi-Chieh Yang, Gin-Ho Lo, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Chun-Yen Lin, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Shui-Yi Tung, Chi-Ming Tai, Chih-Wen Lin, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Ming-Lun Yeh, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Ming-Lung Yu, Wan-Long Chuang, null null
Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan. Journal of gastroenterology and hepatology 36 (8) (2021)
Chen-Hua Liu, Chi-Yi Chen, Wei-Wen Su, Kuo-Chih Tseng, Ching-Chu Lo, Chun-Jen Liu, Jyh-Jou Chen, Cheng-Yuan Peng, Yu-Lueng Shih, Sheng-Shun Yang, Chia-Sheng Huang, Ke-Jhang Huang, Chi-Yang Chang, Ming-Chang Tsai, Wei-Yu Kao, Yo-Jen Fang, Po-Yueh Chen, Pei-Yuan Su, Chih-Wei Tseng, Jow-Jyh Huang, Pei-Lun Lee, Hsueh-Chou Lai, Tsai-Yuan Hsieh, Chung-Hsin Chang, Yi-Jie Huang, Fu-Jen Lee, Chun-Chao Chang, Jia-Horng Kao
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment. Gut 71 (1) (2021)
Yi-Shin Huang, Chen-Yi Wu, Ting-Tsung Chang, Cheng-Yuan Peng, Gin-Ho Lo, Chao-Wei Hsu, Chi-Tan Hu, Yi-Hsiang Huang
Drug-induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in Taiwan. Liver international : official journal of the International Association for the Study of the Liver 41 (11) (2021)
Wei-Fan Hsu, Pei-Chein Tsai, Chi-Yi Chen, Kuo-Chih Tseng, Hsueh-Chou Lai, Hsing-Tao Kuo, Chao-Hung Hung, Shui-Yi Tung, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Ron-Nan Chien, Chun-Yen Lin, Chi-Chieh Yang, Gin-Ho Lo, Chi-Ming Tai, Chih-Wen Lin, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Ming-Jong Bair, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu, Cheng-Yuan Peng
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort). Journal of gastroenterology and hepatology 36 (10) (2021)
Hung-Wei Wang, Po-Heng Chuang, Wen-Pang Su, Jung-Ta Kao, Wei-Fan Hsu, Chun-Che Lin, Guan-Tarn Huang, Jaw-Town Lin, Hsueh-Chou Lai, Cheng-Yuan Peng
On-Treatment Albumin-Bilirubin Grade: Predictor of Response and Outcome of Sorafenib-Regorafenib Sequential Therapy in Patients with Unresectable Hepatocellular Carcinoma. Cancers 13 (15) (2021)
Cheng-Yuan Peng, Chien-Hung Chen
On-treatment predictors of hepatocellular carcinoma in patients with chronic hepatitis B. Liver international : official journal of the International Association for the Study of the Liver 41 (7) (2021)
Chen-Hua Liu, Cheng-Yuan Peng, Wei-Yu Kao, Sheng-Shun Yang, Yu-Lueng Shih, Chin-Lin Lin, Meng-Kun Tsai, Chih-Yuan Lee, Chun-Chao Chang, Jo-Hsuan Wu, Chun-Jen Liu, Tung-Hung Su, Tai-Chung Tseng, Pei-Jer Chen, Jia-Horng Kao
Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment. Alimentary pharmacology & therapeutics (2021)
Chun-Jen Liu, I-Shyan Sheen, Chi-Yi Chen, Wan-Long Chuang, Horng-Yuan Wang, Kuo-Chih Tseng, Ting-Tsung Chang, Jenny Yang, Benedetta Massetto, Vithika Suri, Gregory Camus, Deyuan Jiang, Fangqiu Zhang, Anuj Gaggar, Tsung-Hui Hu, Yu-Chun Hsu, Gin-Ho Lo, Chi-Jen Chu, Jyh-Jou Chen, Cheng-Yuan Peng, Rong-Nan Chien, Pei-Jer Chen
Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up 108 Weeks Posttreatment. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Chen-Hua Liu, Cheng-Yuan Peng, Yu-Jen Fang, Wei-Yu Kao, Sheng-Shun Yang, Cheng-Kuan Lin, Hsueh-Chou Lai, Wen-Pang Su, Sheng-Uei Fang, Chun-Chao Chang, Tung-Hung Su, Chun-Jen Liu, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis. Scientific reports 10 (1) (2020)
Wei-Fan Hsu, Chi-Yi Chen, Kuo-Chih Tseng, Hsueh-Chou Lai, Hsing-Tao Kuo, Chao-Hung Hung, Shui-Yi Tung, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Yung-Chang Lin, Chi-Chieh Yang, Gin-Ho Lo, Chi-Ming Tai, Chih-Wen Lin, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Ming-Jong Bair, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Pei-Chien Tsai, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu, Cheng-Yuan Peng
Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis. Scientific reports 10 (1) (2020)
Hung-Wei Wang, Hsueh-Chou Lai, Tsung-Hui Hu, Wen-Pang Su, Sheng-Nan Lu, Chia-Hsin Lin, Chao-Hung Hung, Po-Heng Chuang, Jing-Houng Wang, Mei-Hsuan Lee, Chien-Hung Chen, Cheng-Yuan Peng
On-Treatment Changes in FIB-4 and 1-Year FIB-4 Values Help Identify Patients with Chronic Hepatitis B Receiving Entecavir Therapy Who Have the Lowest Risk of Hepatocellular Carcinoma. Cancers 12 (5) (2020)
Chen-Hua Liu, Sheng-Shun Yang, Cheng-Yuan Peng, Woan-Tyy Lin, Chun-Jen Liu, Tung-Hung Su, Tai-Chung Tseng, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment. Journal of viral hepatitis 27 (6) (2020)
Chiao-Fang Teng, Tsai-Chung Li, Hsi-Yuan Huang, Jia-Hui Lin, Wen-Shu Chen, Woei-Cherng Shyu, Han-Chieh Wu, Cheng-Yuan Peng, Ih-Jen Su, Long-Bin Jeng
Next-Generation Sequencing-Based Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma Predicts Hepatocellular Carcinoma Recurrence. Viruses 12 (8) (2020)
Pei-Chien Tsai, Chi-Yi Chen, Hsing-Tao Kuo, Chao-Hung Hung, Kuo-Chih Tseng, Hsueh-Chou Lai, Cheng-Yuan Peng, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chi-Chieh Yang, Gin-Ho Lo, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Ming-Jong Bair, Chun-Yen Lin, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Shui-Yi Tung, Chi-Ming Tai, Chih-Wen Lin, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Ming-Lun Yeh, Chung-Feng Huang, Meng-Hsuan Hsieh, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chung, Chiao-Li Khale Ke, Ming-Lung Yu
Successful Antiviral Therapy Reduces Risk of Schizophrenia Among Chronic Hepatitis C Patients: A Nationwide Real-World Taiwanese Cohort (T-COACH). Open forum infectious diseases 7 (10) (2020)
Cheng-Yuan Peng
Editorial: a baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients-same score, different outcomes. Alimentary pharmacology & therapeutics 48 (8) (2019)
Cheng-Yuan Peng
Editorial: identifying candidates for pegylated interferon add-on to entecavir therapy in patients with HBeAg-positive chronic hepatitis B. Alimentary pharmacology & therapeutics 49 (5) (2019)
Wei-Fan Hsu, Hsueh-Chou Lai, Wen-Pang Su, Chia-Hsin Lin, Po-Heng Chuang, Sheng-Hung Chen, Hung-Yao Chen, Hung-Wei Wang, Guan-Tarn Huang, Cheng-Yuan Peng
Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents. BMC gastroenterology 19 (1) (2019)
Wei-Fan Hsu, Shi-Hang Yu, Jaw-Town Lin, Jaw-Ching Wu, Ming-Chih Hou, Yi-Hsiang Huang, Chun-Ying Wu, Cheng-Yuan Peng
Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study. Gastroenterology research and practice 2019 (2019)
Steven Flamm, Cheng-Yuan Peng, Oren Shibolet, Ronald Nahass, Peggy Hwang, Eliav Barr, Michael N Robertson, Barbara A Haber
Efficacy and Safety of Elbasvir/Grazoprevir in Hepatitis C Virus GT1- and GT4-Infected People Aged 65 Years or Older. Gerontology & geriatric medicine 5 (2019)
Hung-Wei Wang, Hsueh-Chou Lai, Tsung-Hui Hu, Wen-Pang Su, Sheng-Nan Lu, Chia-Hsin Lin, Chao-Hung Hung, Po-Heng Chuang, Jing-Houng Wang, Mei-Hsuan Lee, Chien-Hung Chen, Cheng-Yuan Peng
Stratification of hepatocellular carcinoma risk through modified FIB-4 index in chronic hepatitis B patients on entecavir therapy. Journal of gastroenterology and hepatology 34 (2) (2018)
Hung-Hsien Chiang, Chuan-Mo Lee, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu, Hsueh-Chou Lai, Wen-Pang Su, Chia-Hsin Lin, Cheng-Yuan Peng, Chien-Hung Chen
A combination of the on-treatment FIB-4 and alpha-foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir. Liver international : official journal of the International Association for the Study of the Liver 38 (11) (2018)
Chen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, Tsai-Yuan Hsieh, Yi-Hsiang Huang, Wei-Wen Su, Pin-Nan Cheng, Chih-Lin Lin, Ching-Chu Lo, Chi-Yi Chen, Jyh-Jou Chen, Qian Ma, Craig Brooks-Rooney, Jia-Horng Kao
Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan. Alimentary pharmacology & therapeutics 48 (11-12) (2018)
Wei-Fan Hsu, Chuen-Fei Chen, Hsueh-Chou Lai, Wen-Pang Su, Chia-Hsin Lin, Po-Heng Chuang, Sheng-Hung Chen, Ching-Hsiang Chen, Hung-Wei Wang, Guan-Tarn Huang, Cheng-Yuan Peng
Trajectories of serum hepatitis B surface antigen kinetics in patients with chronic hepatitis B receiving long-term nucleos(t)ide analogue therapy. Liver international : official journal of the International Association for the Study of the Liver 38 (4) (2017)
K Rajender Reddy, Stanislas Pol, Paul J Thuluvath, Hiromitsu Kumada, Joji Toyota, Kazuaki Chayama, James Levin, Eric J Lawitz, Adrian Gadano, Wayne Ghesquiere, Guido Gerken, Maurizia R Brunetto, Cheng-Yuan Peng, Marcelo Silva, Simone I Strasser, Jeong Heo, Fiona McPhee, Zhaohui Liu, Rong Yang, Misti Linaberry, Stephanie Noviello
Long-term follow-up of clinical trial patients treated for chronic HCV infection with daclatasvir-based regimens. Liver international : official journal of the International Association for the Study of the Liver 38 (5) (2017)

Cheng-Yuan Peng.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Cheng-Yuan Peng